Category Specific RSS

prostate cancer

Genetic Technologies’ geneType prostate cancer risk assessment test validated in scientific publication

In 2022, over 24k Aussie males were diagnosed with prostate cancer. One of the most commonly diagnosed cancers, it was…

2 years ago

Telix submits FDA application for new prostate cancer imaging product

It may soon be easier for prostate cancer to be diagnosed at an early stage with Telix Pharmaceuticals (ASX: TLX)…

5 years ago